nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—migraine—Prednisone—systemic lupus erythematosus	0.662	1	CpDpCtD
Ergotamine—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0283	0.127	CbGbCtD
Ergotamine—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0202	0.0907	CbGbCtD
Ergotamine—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0153	0.0687	CbGbCtD
Ergotamine—ABCB1—Betamethasone—systemic lupus erythematosus	0.0131	0.059	CbGbCtD
Ergotamine—ABCB1—Prednisolone—systemic lupus erythematosus	0.013	0.0582	CbGbCtD
Ergotamine—HTR2B—cardial valve—systemic lupus erythematosus	0.0126	0.195	CbGeAlD
Ergotamine—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0123	0.0552	CbGbCtD
Ergotamine—ABCB1—Prednisone—systemic lupus erythematosus	0.0122	0.055	CbGbCtD
Ergotamine—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0121	0.0543	CbGbCtD
Ergotamine—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0116	0.0521	CbGbCtD
Ergotamine—HTR2C—choroid plexus—systemic lupus erythematosus	0.0108	0.167	CbGeAlD
Ergotamine—CYP3A4—Dapsone—systemic lupus erythematosus	0.0106	0.0475	CbGbCtD
Ergotamine—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00917	0.0412	CbGbCtD
Ergotamine—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00917	0.0412	CbGbCtD
Ergotamine—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00787	0.0353	CbGbCtD
Ergotamine—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00777	0.0349	CbGbCtD
Ergotamine—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00764	0.0343	CbGbCtD
Ergotamine—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00736	0.0331	CbGbCtD
Ergotamine—CYP3A4—Prednisone—systemic lupus erythematosus	0.00733	0.0329	CbGbCtD
Ergotamine—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00695	0.0312	CbGbCtD
Ergotamine—ABCB1—Methotrexate—systemic lupus erythematosus	0.00614	0.0276	CbGbCtD
Ergotamine—HTR2A—choroid plexus—systemic lupus erythematosus	0.00543	0.084	CbGeAlD
Ergotamine—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00458	0.0206	CbGbCtD
Ergotamine—Gangrene—Mycophenolate mofetil—systemic lupus erythematosus	0.00253	0.0933	CcSEcCtD
Ergotamine—CYP1A2—urine—systemic lupus erythematosus	0.00186	0.0287	CbGeAlD
Ergotamine—Paresthesia of limbs—Methotrexate—systemic lupus erythematosus	0.00163	0.0602	CcSEcCtD
Ergotamine—HTR2A—urine—systemic lupus erythematosus	0.00145	0.0225	CbGeAlD
Ergotamine—CYP3A4—urine—systemic lupus erythematosus	0.00135	0.0208	CbGeAlD
Ergotamine—HTR1A—blood plasma—systemic lupus erythematosus	0.00127	0.0197	CbGeAlD
Ergotamine—HTR1F—nervous system—systemic lupus erythematosus	0.00115	0.0177	CbGeAlD
Ergotamine—HTR1F—central nervous system—systemic lupus erythematosus	0.0011	0.017	CbGeAlD
Ergotamine—HTR1E—nervous system—systemic lupus erythematosus	0.000992	0.0153	CbGeAlD
Ergotamine—CYP1A2—blood plasma—systemic lupus erythematosus	0.00097	0.015	CbGeAlD
Ergotamine—HTR1E—central nervous system—systemic lupus erythematosus	0.000955	0.0148	CbGeAlD
Ergotamine—ADRA1B—kidney—systemic lupus erythematosus	0.000947	0.0146	CbGeAlD
Ergotamine—ADRA2A—blood plasma—systemic lupus erythematosus	0.000892	0.0138	CbGeAlD
Ergotamine—HTR2A—endothelium—systemic lupus erythematosus	0.000854	0.0132	CbGeAlD
Ergotamine—HTR1D—connective tissue—systemic lupus erythematosus	0.000813	0.0126	CbGeAlD
Ergotamine—Cyanosis—Mycophenolate mofetil—systemic lupus erythematosus	0.00078	0.0288	CcSEcCtD
Ergotamine—HTR2A—blood plasma—systemic lupus erythematosus	0.000759	0.0117	CbGeAlD
Ergotamine—CYP3A4—blood plasma—systemic lupus erythematosus	0.000702	0.0109	CbGeAlD
Ergotamine—HTR1D—kidney—systemic lupus erythematosus	0.000692	0.0107	CbGeAlD
Ergotamine—HTR2B—skin of body—systemic lupus erythematosus	0.000683	0.0106	CbGeAlD
Ergotamine—HTR2B—cortex of kidney—systemic lupus erythematosus	0.000627	0.00969	CbGeAlD
Ergotamine—ADRA1B—nervous system—systemic lupus erythematosus	0.000621	0.0096	CbGeAlD
Ergotamine—ADRA1D—nervous system—systemic lupus erythematosus	0.000608	0.00939	CbGeAlD
Ergotamine—ADRA1B—central nervous system—systemic lupus erythematosus	0.000598	0.00924	CbGeAlD
Ergotamine—ADRA1D—central nervous system—systemic lupus erythematosus	0.000585	0.00904	CbGeAlD
Ergotamine—Vertigo—Dapsone—systemic lupus erythematosus	0.00054	0.0199	CcSEcCtD
Ergotamine—HTR2B—tendon—systemic lupus erythematosus	0.00052	0.00804	CbGeAlD
Ergotamine—ABCB1—blood plasma—systemic lupus erythematosus	0.000497	0.00768	CbGeAlD
Ergotamine—Tachycardia—Dapsone—systemic lupus erythematosus	0.000478	0.0176	CcSEcCtD
Ergotamine—ADRA2A—connective tissue—systemic lupus erythematosus	0.000475	0.00734	CbGeAlD
Ergotamine—HTR1B—nervous system—systemic lupus erythematosus	0.000469	0.00725	CbGeAlD
Ergotamine—ADRA1A—lymphoid tissue—systemic lupus erythematosus	0.000457	0.00706	CbGeAlD
Ergotamine—HTR2B—lung—systemic lupus erythematosus	0.000456	0.00705	CbGeAlD
Ergotamine—HTR1D—nervous system—systemic lupus erythematosus	0.000454	0.00702	CbGeAlD
Ergotamine—HTR1B—central nervous system—systemic lupus erythematosus	0.000452	0.00698	CbGeAlD
Ergotamine—HTR2C—nervous system—systemic lupus erythematosus	0.00045	0.00695	CbGeAlD
Ergotamine—Cyanosis—Methotrexate—systemic lupus erythematosus	0.000442	0.0163	CcSEcCtD
Ergotamine—HTR1D—central nervous system—systemic lupus erythematosus	0.000437	0.00676	CbGeAlD
Ergotamine—HTR2C—central nervous system—systemic lupus erythematosus	0.000433	0.00669	CbGeAlD
Ergotamine—HTR2B—nervous system—systemic lupus erythematosus	0.000423	0.00653	CbGeAlD
Ergotamine—HTR2B—central nervous system—systemic lupus erythematosus	0.000407	0.00629	CbGeAlD
Ergotamine—SLC6A2—lung—systemic lupus erythematosus	0.000405	0.00627	CbGeAlD
Ergotamine—HTR2A—connective tissue—systemic lupus erythematosus	0.000404	0.00624	CbGeAlD
Ergotamine—ADRA2A—cortex of kidney—systemic lupus erythematosus	0.000394	0.00609	CbGeAlD
Ergotamine—HTR1A—nervous system—systemic lupus erythematosus	0.000379	0.00585	CbGeAlD
Ergotamine—SLC6A2—nervous system—systemic lupus erythematosus	0.000375	0.0058	CbGeAlD
Ergotamine—DRD2—lung—systemic lupus erythematosus	0.000369	0.00571	CbGeAlD
Ergotamine—HTR1A—central nervous system—systemic lupus erythematosus	0.000365	0.00563	CbGeAlD
Ergotamine—SLC6A2—central nervous system—systemic lupus erythematosus	0.000361	0.00559	CbGeAlD
Ergotamine—ADRA1A—nervous system—systemic lupus erythematosus	0.000349	0.00539	CbGeAlD
Ergotamine—HTR2A—kidney—systemic lupus erythematosus	0.000344	0.00531	CbGeAlD
Ergotamine—DRD2—nervous system—systemic lupus erythematosus	0.000342	0.00529	CbGeAlD
Ergotamine—ADRA1A—central nervous system—systemic lupus erythematosus	0.000336	0.00519	CbGeAlD
Ergotamine—DRD2—central nervous system—systemic lupus erythematosus	0.000329	0.00509	CbGeAlD
Ergotamine—ADRA2A—tendon—systemic lupus erythematosus	0.000327	0.00505	CbGeAlD
Ergotamine—CYP3A4—kidney—systemic lupus erythematosus	0.000318	0.00492	CbGeAlD
Ergotamine—Vomiting—Dapsone—systemic lupus erythematosus	0.000312	0.0115	CcSEcCtD
Ergotamine—CYP1A2—lung—systemic lupus erythematosus	0.000312	0.00482	CbGeAlD
Ergotamine—Nausea—Dapsone—systemic lupus erythematosus	0.000291	0.0107	CcSEcCtD
Ergotamine—Myalgia—Azathioprine—systemic lupus erythematosus	0.000289	0.0107	CcSEcCtD
Ergotamine—Vertigo—Leflunomide—systemic lupus erythematosus	0.000288	0.0106	CcSEcCtD
Ergotamine—ADRA2A—lung—systemic lupus erythematosus	0.000287	0.00443	CbGeAlD
Ergotamine—Hypoaesthesia—Cyclosporine—systemic lupus erythematosus	0.000283	0.0104	CcSEcCtD
Ergotamine—Bradycardia—Mycophenolate mofetil—systemic lupus erythematosus	0.000282	0.0104	CcSEcCtD
Ergotamine—HTR2A—tendon—systemic lupus erythematosus	0.000278	0.00429	CbGeAlD
Ergotamine—Hypertension—Leflunomide—systemic lupus erythematosus	0.000277	0.0102	CcSEcCtD
Ergotamine—Hypoaesthesia—Mycophenolate mofetil—systemic lupus erythematosus	0.000276	0.0102	CcSEcCtD
Ergotamine—Myalgia—Leflunomide—systemic lupus erythematosus	0.000273	0.0101	CcSEcCtD
Ergotamine—ADRA2A—nervous system—systemic lupus erythematosus	0.000265	0.0041	CbGeAlD
Ergotamine—Bradycardia—Prednisolone—systemic lupus erythematosus	0.000263	0.00971	CcSEcCtD
Ergotamine—Bradycardia—Hydrocortisone—systemic lupus erythematosus	0.000257	0.00949	CcSEcCtD
Ergotamine—ABCB1—nephron tubule—systemic lupus erythematosus	0.000256	0.00396	CbGeAlD
Ergotamine—ADRA2A—central nervous system—systemic lupus erythematosus	0.000256	0.00395	CbGeAlD
Ergotamine—Tachycardia—Leflunomide—systemic lupus erythematosus	0.000255	0.00942	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Azathioprine—systemic lupus erythematosus	0.000253	0.00931	CcSEcCtD
Ergotamine—HTR2A—lung—systemic lupus erythematosus	0.000244	0.00377	CbGeAlD
Ergotamine—Bradycardia—Triamcinolone—systemic lupus erythematosus	0.000242	0.00893	CcSEcCtD
Ergotamine—Bradycardia—Methylprednisolone—systemic lupus erythematosus	0.000242	0.00891	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Leflunomide—systemic lupus erythematosus	0.000238	0.00879	CcSEcCtD
Ergotamine—Paraesthesia—Leflunomide—systemic lupus erythematosus	0.000235	0.00867	CcSEcCtD
Ergotamine—HTR2A—nervous system—systemic lupus erythematosus	0.000226	0.00349	CbGeAlD
Ergotamine—ABCB1—kidney—systemic lupus erythematosus	0.000225	0.00348	CbGeAlD
Ergotamine—Pain—Leflunomide—systemic lupus erythematosus	0.000224	0.00825	CcSEcCtD
Ergotamine—Vertigo—Cyclosporine—systemic lupus erythematosus	0.000222	0.0082	CcSEcCtD
Ergotamine—Bradycardia—Dexamethasone—systemic lupus erythematosus	0.00022	0.0081	CcSEcCtD
Ergotamine—Bradycardia—Betamethasone—systemic lupus erythematosus	0.00022	0.0081	CcSEcCtD
Ergotamine—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000219	0.00339	CbGeAlD
Ergotamine—HTR2A—central nervous system—systemic lupus erythematosus	0.000217	0.00336	CbGeAlD
Ergotamine—Vertigo—Mycophenolate mofetil—systemic lupus erythematosus	0.000217	0.008	CcSEcCtD
Ergotamine—Hypertension—Cyclosporine—systemic lupus erythematosus	0.000214	0.00788	CcSEcCtD
Ergotamine—Myalgia—Cyclosporine—systemic lupus erythematosus	0.000211	0.00777	CcSEcCtD
Ergotamine—CYP3A4—nervous system—systemic lupus erythematosus	0.000209	0.00323	CbGeAlD
Ergotamine—Hypertension—Mycophenolate mofetil—systemic lupus erythematosus	0.000208	0.00769	CcSEcCtD
Ergotamine—Myalgia—Mycophenolate mofetil—systemic lupus erythematosus	0.000206	0.00758	CcSEcCtD
Ergotamine—Vertigo—Prednisolone—systemic lupus erythematosus	0.000202	0.00746	CcSEcCtD
Ergotamine—CYP3A4—central nervous system—systemic lupus erythematosus	0.000201	0.00311	CbGeAlD
Ergotamine—Vertigo—Hydrocortisone—systemic lupus erythematosus	0.000198	0.00729	CcSEcCtD
Ergotamine—Hypertension—Prednisolone—systemic lupus erythematosus	0.000194	0.00717	CcSEcCtD
Ergotamine—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000194	0.00299	CbGeAlD
Ergotamine—Tachycardia—Mycophenolate mofetil—systemic lupus erythematosus	0.000192	0.00709	CcSEcCtD
Ergotamine—Bradycardia—Prednisone—systemic lupus erythematosus	0.000191	0.00706	CcSEcCtD
Ergotamine—Hypertension—Hydrocortisone—systemic lupus erythematosus	0.00019	0.007	CcSEcCtD
Ergotamine—Asthenia—Leflunomide—systemic lupus erythematosus	0.000188	0.00692	CcSEcCtD
Ergotamine—Myalgia—Hydrocortisone—systemic lupus erythematosus	0.000187	0.00691	CcSEcCtD
Ergotamine—Vertigo—Triamcinolone—systemic lupus erythematosus	0.000186	0.00686	CcSEcCtD
Ergotamine—Vertigo—Methylprednisolone—systemic lupus erythematosus	0.000186	0.00685	CcSEcCtD
Ergotamine—Pruritus—Leflunomide—systemic lupus erythematosus	0.000185	0.00683	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Cyclosporine—systemic lupus erythematosus	0.000184	0.00679	CcSEcCtD
Ergotamine—Paraesthesia—Cyclosporine—systemic lupus erythematosus	0.000181	0.00669	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.00018	0.00662	CcSEcCtD
Ergotamine—Tachycardia—Prednisolone—systemic lupus erythematosus	0.000179	0.00662	CcSEcCtD
Ergotamine—Hypertension—Triamcinolone—systemic lupus erythematosus	0.000179	0.00659	CcSEcCtD
Ergotamine—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.000178	0.00658	CcSEcCtD
Ergotamine—Paraesthesia—Mycophenolate mofetil—systemic lupus erythematosus	0.000177	0.00652	CcSEcCtD
Ergotamine—Myalgia—Triamcinolone—systemic lupus erythematosus	0.000176	0.0065	CcSEcCtD
Ergotamine—ABCB1—bone marrow—systemic lupus erythematosus	0.000176	0.00272	CbGeAlD
Ergotamine—Vomiting—Azathioprine—systemic lupus erythematosus	0.000176	0.0065	CcSEcCtD
Ergotamine—Myalgia—Methylprednisolone—systemic lupus erythematosus	0.000176	0.00649	CcSEcCtD
Ergotamine—Tachycardia—Hydrocortisone—systemic lupus erythematosus	0.000175	0.00646	CcSEcCtD
Ergotamine—Pain—Cyclosporine—systemic lupus erythematosus	0.000173	0.00637	CcSEcCtD
Ergotamine—Vertigo—Betamethasone—systemic lupus erythematosus	0.000169	0.00623	CcSEcCtD
Ergotamine—Vertigo—Dexamethasone—systemic lupus erythematosus	0.000169	0.00623	CcSEcCtD
Ergotamine—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000169	0.00621	CcSEcCtD
Ergotamine—Vomiting—Leflunomide—systemic lupus erythematosus	0.000166	0.00614	CcSEcCtD
Ergotamine—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.000165	0.00609	CcSEcCtD
Ergotamine—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.000165	0.00608	CcSEcCtD
Ergotamine—Nausea—Azathioprine—systemic lupus erythematosus	0.000165	0.00607	CcSEcCtD
Ergotamine—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.000165	0.00607	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000164	0.00603	CcSEcCtD
Ergotamine—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000162	0.00598	CcSEcCtD
Ergotamine—Hypertension—Betamethasone—systemic lupus erythematosus	0.000162	0.00598	CcSEcCtD
Ergotamine—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000161	0.00594	CcSEcCtD
Ergotamine—Myalgia—Dexamethasone—systemic lupus erythematosus	0.00016	0.0059	CcSEcCtD
Ergotamine—Myalgia—Betamethasone—systemic lupus erythematosus	0.00016	0.0059	CcSEcCtD
Ergotamine—ABCB1—lung—systemic lupus erythematosus	0.00016	0.00247	CbGeAlD
Ergotamine—Pain—Prednisolone—systemic lupus erythematosus	0.000157	0.0058	CcSEcCtD
Ergotamine—Nausea—Leflunomide—systemic lupus erythematosus	0.000155	0.00573	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000154	0.00568	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000154	0.00567	CcSEcCtD
Ergotamine—Pain—Hydrocortisone—systemic lupus erythematosus	0.000154	0.00566	CcSEcCtD
Ergotamine—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000152	0.0056	CcSEcCtD
Ergotamine—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000151	0.00558	CcSEcCtD
Ergotamine—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.00015	0.00552	CcSEcCtD
Ergotamine—Tachycardia—Betamethasone—systemic lupus erythematosus	0.00015	0.00552	CcSEcCtD
Ergotamine—ABCB1—nervous system—systemic lupus erythematosus	0.000148	0.00229	CbGeAlD
Ergotamine—Vertigo—Prednisone—systemic lupus erythematosus	0.000147	0.00542	CcSEcCtD
Ergotamine—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000145	0.00534	CcSEcCtD
Ergotamine—Pain—Triamcinolone—systemic lupus erythematosus	0.000145	0.00533	CcSEcCtD
Ergotamine—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000143	0.00527	CcSEcCtD
Ergotamine—ABCB1—central nervous system—systemic lupus erythematosus	0.000142	0.0022	CbGeAlD
Ergotamine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000141	0.00521	CcSEcCtD
Ergotamine—Hypertension—Prednisone—systemic lupus erythematosus	0.000141	0.00521	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.00014	0.00515	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.00014	0.00515	CcSEcCtD
Ergotamine—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000139	0.00514	CcSEcCtD
Ergotamine—Myalgia—Prednisone—systemic lupus erythematosus	0.000139	0.00514	CcSEcCtD
Ergotamine—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000138	0.00508	CcSEcCtD
Ergotamine—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000138	0.00508	CcSEcCtD
Ergotamine—Pain—Betamethasone—systemic lupus erythematosus	0.000131	0.00484	CcSEcCtD
Ergotamine—Pain—Dexamethasone—systemic lupus erythematosus	0.000131	0.00484	CcSEcCtD
Ergotamine—Tachycardia—Prednisone—systemic lupus erythematosus	0.00013	0.00481	CcSEcCtD
Ergotamine—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000129	0.00475	CcSEcCtD
Ergotamine—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000128	0.00474	CcSEcCtD
Ergotamine—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000127	0.00468	CcSEcCtD
Ergotamine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000125	0.00462	CcSEcCtD
Ergotamine—Vertigo—Methotrexate—systemic lupus erythematosus	0.000123	0.00453	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000122	0.00449	CcSEcCtD
Ergotamine—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000121	0.00447	CcSEcCtD
Ergotamine—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000121	0.00446	CcSEcCtD
Ergotamine—Nausea—Cyclosporine—systemic lupus erythematosus	0.00012	0.00442	CcSEcCtD
Ergotamine—Paraesthesia—Prednisone—systemic lupus erythematosus	0.00012	0.00442	CcSEcCtD
Ergotamine—Pruritus—Triamcinolone—systemic lupus erythematosus	0.00012	0.00441	CcSEcCtD
Ergotamine—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000119	0.0044	CcSEcCtD
Ergotamine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000117	0.00432	CcSEcCtD
Ergotamine—Myalgia—Methotrexate—systemic lupus erythematosus	0.000116	0.00429	CcSEcCtD
Ergotamine—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000114	0.00421	CcSEcCtD
Ergotamine—Asthenia—Dexamethasone—systemic lupus erythematosus	0.00011	0.00406	CcSEcCtD
Ergotamine—Asthenia—Betamethasone—systemic lupus erythematosus	0.00011	0.00406	CcSEcCtD
Ergotamine—Nausea—Prednisolone—systemic lupus erythematosus	0.000109	0.00403	CcSEcCtD
Ergotamine—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000109	0.004	CcSEcCtD
Ergotamine—Pruritus—Betamethasone—systemic lupus erythematosus	0.000109	0.004	CcSEcCtD
Ergotamine—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000107	0.00396	CcSEcCtD
Ergotamine—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000107	0.00395	CcSEcCtD
Ergotamine—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000107	0.00393	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000102	0.00375	CcSEcCtD
Ergotamine—Nausea—Triamcinolone—systemic lupus erythematosus	0.0001	0.0037	CcSEcCtD
Ergotamine—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.0001	0.0037	CcSEcCtD
Ergotamine—Nausea—Methylprednisolone—systemic lupus erythematosus	0.0001	0.00369	CcSEcCtD
Ergotamine—Vomiting—Dexamethasone—systemic lupus erythematosus	9.75e-05	0.0036	CcSEcCtD
Ergotamine—Vomiting—Betamethasone—systemic lupus erythematosus	9.75e-05	0.0036	CcSEcCtD
Ergotamine—Asthenia—Prednisone—systemic lupus erythematosus	9.58e-05	0.00353	CcSEcCtD
Ergotamine—Pain—Methotrexate—systemic lupus erythematosus	9.55e-05	0.00352	CcSEcCtD
Ergotamine—Pruritus—Prednisone—systemic lupus erythematosus	9.45e-05	0.00348	CcSEcCtD
Ergotamine—Nausea—Betamethasone—systemic lupus erythematosus	9.11e-05	0.00336	CcSEcCtD
Ergotamine—Nausea—Dexamethasone—systemic lupus erythematosus	9.11e-05	0.00336	CcSEcCtD
Ergotamine—Vomiting—Prednisone—systemic lupus erythematosus	8.49e-05	0.00313	CcSEcCtD
Ergotamine—Asthenia—Methotrexate—systemic lupus erythematosus	8.01e-05	0.00295	CcSEcCtD
Ergotamine—Nausea—Prednisone—systemic lupus erythematosus	7.94e-05	0.00293	CcSEcCtD
Ergotamine—Pruritus—Methotrexate—systemic lupus erythematosus	7.9e-05	0.00291	CcSEcCtD
Ergotamine—Vomiting—Methotrexate—systemic lupus erythematosus	7.1e-05	0.00262	CcSEcCtD
Ergotamine—Nausea—Methotrexate—systemic lupus erythematosus	6.63e-05	0.00245	CcSEcCtD
Ergotamine—HTR1A—Signaling Pathways—JAK1—systemic lupus erythematosus	5.17e-06	0.00022	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—JAK1—systemic lupus erythematosus	5.14e-06	0.000219	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—TGFB1—systemic lupus erythematosus	5.12e-06	0.000218	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PRL—systemic lupus erythematosus	5.08e-06	0.000216	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CCR5—systemic lupus erythematosus	5.07e-06	0.000216	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—TYK2—systemic lupus erythematosus	5.06e-06	0.000215	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.04e-06	0.000215	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—IL2—systemic lupus erythematosus	5.02e-06	0.000214	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—EP300—systemic lupus erythematosus	5.02e-06	0.000214	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CCL2—systemic lupus erythematosus	5.02e-06	0.000214	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL2RA—systemic lupus erythematosus	5e-06	0.000213	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—CCL2—systemic lupus erythematosus	4.98e-06	0.000212	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—TYK2—systemic lupus erythematosus	4.97e-06	0.000212	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CD80—systemic lupus erythematosus	4.97e-06	0.000212	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—IL2—systemic lupus erythematosus	4.96e-06	0.000211	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—C3—systemic lupus erythematosus	4.96e-06	0.000211	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—JAK1—systemic lupus erythematosus	4.92e-06	0.00021	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CCL2—systemic lupus erythematosus	4.92e-06	0.00021	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CCR5—systemic lupus erythematosus	4.9e-06	0.000209	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CCR5—systemic lupus erythematosus	4.87e-06	0.000208	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—TYK2—systemic lupus erythematosus	4.87e-06	0.000208	CbGpPWpGaD
Ergotamine—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	4.84e-06	0.000206	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.83e-06	0.000206	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—F2—systemic lupus erythematosus	4.82e-06	0.000205	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.8e-06	0.000205	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—IL2—systemic lupus erythematosus	4.79e-06	0.000204	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—C3—systemic lupus erythematosus	4.79e-06	0.000204	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—IL2—systemic lupus erythematosus	4.77e-06	0.000203	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—C3—systemic lupus erythematosus	4.76e-06	0.000203	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.76e-06	0.000203	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CCR5—systemic lupus erythematosus	4.66e-06	0.000199	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—IL2—systemic lupus erythematosus	4.63e-06	0.000197	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.63e-06	0.000197	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CD80—systemic lupus erythematosus	4.62e-06	0.000197	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CCL2—systemic lupus erythematosus	4.62e-06	0.000197	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.6e-06	0.000196	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—IL2—systemic lupus erythematosus	4.56e-06	0.000194	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TYK2—systemic lupus erythematosus	4.56e-06	0.000194	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—C3—systemic lupus erythematosus	4.56e-06	0.000194	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—IL2—systemic lupus erythematosus	4.56e-06	0.000194	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—JAK1—systemic lupus erythematosus	4.54e-06	0.000193	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—TYK2—systemic lupus erythematosus	4.53e-06	0.000193	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.52e-06	0.000193	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—NOS3—systemic lupus erythematosus	4.48e-06	0.000191	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—JAK1—systemic lupus erythematosus	4.47e-06	0.00019	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TYK2—systemic lupus erythematosus	4.46e-06	0.00019	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—IL2—systemic lupus erythematosus	4.46e-06	0.00019	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	4.39e-06	0.000187	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—NOS3—systemic lupus erythematosus	4.38e-06	0.000187	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—JAK1—systemic lupus erythematosus	4.37e-06	0.000186	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.37e-06	0.000186	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—F2—systemic lupus erythematosus	4.35e-06	0.000186	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CCR5—systemic lupus erythematosus	4.3e-06	0.000183	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CCL2—systemic lupus erythematosus	4.3e-06	0.000183	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.24e-06	0.000181	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CCR5—systemic lupus erythematosus	4.23e-06	0.00018	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL2—systemic lupus erythematosus	4.21e-06	0.000179	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—C3—systemic lupus erythematosus	4.2e-06	0.000179	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—F2—systemic lupus erythematosus	4.2e-06	0.000179	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TYK2—systemic lupus erythematosus	4.19e-06	0.000179	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—F2—systemic lupus erythematosus	4.18e-06	0.000178	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CD80—systemic lupus erythematosus	4.17e-06	0.000178	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.17e-06	0.000178	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—IL2—systemic lupus erythematosus	4.15e-06	0.000177	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CCR5—systemic lupus erythematosus	4.14e-06	0.000177	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL2—systemic lupus erythematosus	4.14e-06	0.000176	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—C3—systemic lupus erythematosus	4.14e-06	0.000176	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—NOS3—systemic lupus erythematosus	4.12e-06	0.000175	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.08e-06	0.000174	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.07e-06	0.000173	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—JAK1—systemic lupus erythematosus	4.06e-06	0.000173	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL2—systemic lupus erythematosus	4.05e-06	0.000173	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—C3—systemic lupus erythematosus	4.05e-06	0.000173	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CD80—systemic lupus erythematosus	4.03e-06	0.000172	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CD80—systemic lupus erythematosus	4.01e-06	0.000171	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—F2—systemic lupus erythematosus	4e-06	0.000171	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	4e-06	0.00017	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TYK2—systemic lupus erythematosus	3.9e-06	0.000166	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CCL2—systemic lupus erythematosus	3.88e-06	0.000165	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.88e-06	0.000165	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCR5—systemic lupus erythematosus	3.85e-06	0.000164	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CD80—systemic lupus erythematosus	3.84e-06	0.000164	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—NOS3—systemic lupus erythematosus	3.83e-06	0.000163	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.8e-06	0.000162	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.79e-06	0.000162	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL2—systemic lupus erythematosus	3.79e-06	0.000162	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—IL6—systemic lupus erythematosus	3.78e-06	0.000161	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL2—systemic lupus erythematosus	3.77e-06	0.00016	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—C3—systemic lupus erythematosus	3.76e-06	0.00016	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CCL2—systemic lupus erythematosus	3.75e-06	0.00016	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CCL2—systemic lupus erythematosus	3.73e-06	0.000159	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL2—systemic lupus erythematosus	3.72e-06	0.000158	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—IL6—systemic lupus erythematosus	3.7e-06	0.000158	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—F2—systemic lupus erythematosus	3.69e-06	0.000157	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PPARG—systemic lupus erythematosus	3.65e-06	0.000155	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—F2—systemic lupus erythematosus	3.63e-06	0.000155	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—MMP9—systemic lupus erythematosus	3.59e-06	0.000153	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.58e-06	0.000152	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CCL2—systemic lupus erythematosus	3.57e-06	0.000152	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.57e-06	0.000152	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.56e-06	0.000152	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—F2—systemic lupus erythematosus	3.55e-06	0.000151	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CD80—systemic lupus erythematosus	3.54e-06	0.000151	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TYK2—systemic lupus erythematosus	3.52e-06	0.00015	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—MMP9—systemic lupus erythematosus	3.52e-06	0.00015	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.5e-06	0.000149	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL2—systemic lupus erythematosus	3.49e-06	0.000149	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—IL6—systemic lupus erythematosus	3.49e-06	0.000149	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CD80—systemic lupus erythematosus	3.48e-06	0.000148	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—IL6—systemic lupus erythematosus	3.47e-06	0.000148	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—NOS3—systemic lupus erythematosus	3.46e-06	0.000147	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CD80—systemic lupus erythematosus	3.41e-06	0.000145	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—EP300—systemic lupus erythematosus	3.4e-06	0.000145	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TYK2—systemic lupus erythematosus	3.4e-06	0.000145	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TYK2—systemic lupus erythematosus	3.38e-06	0.000144	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—NOS3—systemic lupus erythematosus	3.34e-06	0.000142	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—EP300—systemic lupus erythematosus	3.33e-06	0.000142	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—NOS3—systemic lupus erythematosus	3.32e-06	0.000142	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.32e-06	0.000141	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—F2—systemic lupus erythematosus	3.3e-06	0.000141	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—MMP9—systemic lupus erythematosus	3.3e-06	0.000141	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.29e-06	0.00014	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—IL6—systemic lupus erythematosus	3.29e-06	0.00014	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CCL2—systemic lupus erythematosus	3.29e-06	0.00014	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—ALB—systemic lupus erythematosus	3.28e-06	0.00014	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL2—systemic lupus erythematosus	3.25e-06	0.000138	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TYK2—systemic lupus erythematosus	3.24e-06	0.000138	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CCL2—systemic lupus erythematosus	3.24e-06	0.000138	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—IL6—systemic lupus erythematosus	3.23e-06	0.000138	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.22e-06	0.000137	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	3.19e-06	0.000136	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NOS3—systemic lupus erythematosus	3.18e-06	0.000135	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CCL2—systemic lupus erythematosus	3.17e-06	0.000135	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CD80—systemic lupus erythematosus	3.17e-06	0.000135	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.16e-06	0.000135	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—NOS3—systemic lupus erythematosus	3.14e-06	0.000134	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—EP300—systemic lupus erythematosus	3.13e-06	0.000133	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MMP9—systemic lupus erythematosus	3.07e-06	0.000131	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.06e-06	0.00013	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3e-06	0.000128	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TYK2—systemic lupus erythematosus	2.99e-06	0.000127	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.97e-06	0.000126	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.96e-06	0.000126	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.96e-06	0.000126	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCL2—systemic lupus erythematosus	2.94e-06	0.000125	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TYK2—systemic lupus erythematosus	2.94e-06	0.000125	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL2—systemic lupus erythematosus	2.93e-06	0.000125	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NOS3—systemic lupus erythematosus	2.93e-06	0.000125	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—IL6—systemic lupus erythematosus	2.92e-06	0.000124	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—EP300—systemic lupus erythematosus	2.91e-06	0.000124	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.9e-06	0.000123	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.89e-06	0.000123	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NOS3—systemic lupus erythematosus	2.88e-06	0.000123	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TYK2—systemic lupus erythematosus	2.88e-06	0.000123	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.88e-06	0.000123	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PTGS2—systemic lupus erythematosus	2.87e-06	0.000122	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL2—systemic lupus erythematosus	2.83e-06	0.000121	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NOS3—systemic lupus erythematosus	2.82e-06	0.00012	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—IL6—systemic lupus erythematosus	2.82e-06	0.00012	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL2—systemic lupus erythematosus	2.82e-06	0.00012	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—IL6—systemic lupus erythematosus	2.8e-06	0.000119	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MMP9—systemic lupus erythematosus	2.77e-06	0.000118	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.76e-06	0.000118	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.76e-06	0.000118	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.75e-06	0.000117	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.72e-06	0.000116	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL2—systemic lupus erythematosus	2.7e-06	0.000115	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—IL6—systemic lupus erythematosus	2.68e-06	0.000114	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MMP9—systemic lupus erythematosus	2.68e-06	0.000114	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TYK2—systemic lupus erythematosus	2.67e-06	0.000114	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.67e-06	0.000114	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MMP9—systemic lupus erythematosus	2.66e-06	0.000114	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.66e-06	0.000113	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—EP300—systemic lupus erythematosus	2.63e-06	0.000112	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NOS3—systemic lupus erythematosus	2.62e-06	0.000112	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MMP9—systemic lupus erythematosus	2.55e-06	0.000109	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.54e-06	0.000108	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—EP300—systemic lupus erythematosus	2.54e-06	0.000108	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.54e-06	0.000108	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.53e-06	0.000108	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—EP300—systemic lupus erythematosus	2.53e-06	0.000108	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	2.52e-06	0.000108	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.5e-06	0.000106	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.49e-06	0.000106	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL2—systemic lupus erythematosus	2.48e-06	0.000106	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL6—systemic lupus erythematosus	2.47e-06	0.000105	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	2.46e-06	0.000105	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.45e-06	0.000104	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL2—systemic lupus erythematosus	2.45e-06	0.000104	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL6—systemic lupus erythematosus	2.43e-06	0.000104	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—EP300—systemic lupus erythematosus	2.42e-06	0.000103	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.41e-06	0.000102	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL2—systemic lupus erythematosus	2.39e-06	0.000102	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.39e-06	0.000102	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—EP300—systemic lupus erythematosus	2.39e-06	0.000102	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL6—systemic lupus erythematosus	2.38e-06	0.000102	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MMP9—systemic lupus erythematosus	2.35e-06	0.0001	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.34e-06	9.99e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MMP9—systemic lupus erythematosus	2.31e-06	9.86e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.31e-06	9.83e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.29e-06	9.76e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.29e-06	9.74e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.27e-06	9.69e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—ALB—systemic lupus erythematosus	2.27e-06	9.67e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MMP9—systemic lupus erythematosus	2.27e-06	9.65e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.26e-06	9.62e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL6—systemic lupus erythematosus	2.23e-06	9.5e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—EP300—systemic lupus erythematosus	2.23e-06	9.5e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL2—systemic lupus erythematosus	2.22e-06	9.48e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL6—systemic lupus erythematosus	2.21e-06	9.43e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.21e-06	9.41e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.2e-06	9.36e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—EP300—systemic lupus erythematosus	2.19e-06	9.35e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL6—systemic lupus erythematosus	2.18e-06	9.31e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	2.17e-06	9.25e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—EP300—systemic lupus erythematosus	2.15e-06	9.15e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.11e-06	9e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MMP9—systemic lupus erythematosus	2.11e-06	8.97e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.1e-06	8.96e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.1e-06	8.94e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.08e-06	8.85e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL6—systemic lupus erythematosus	2.05e-06	8.74e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.03e-06	8.67e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	2.01e-06	8.58e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—EP300—systemic lupus erythematosus	2e-06	8.51e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	1.98e-06	8.46e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.94e-06	8.26e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL6—systemic lupus erythematosus	1.91e-06	8.13e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.91e-06	8.13e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.89e-06	8.06e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.87e-06	7.96e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	1.81e-06	7.72e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.74e-06	7.39e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	1.73e-06	7.38e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL6—systemic lupus erythematosus	1.72e-06	7.34e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL6—systemic lupus erythematosus	1.66e-06	7.09e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL6—systemic lupus erythematosus	1.65e-06	7.05e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—EP300—systemic lupus erythematosus	1.65e-06	7.03e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	1.58e-06	6.75e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL6—systemic lupus erythematosus	1.58e-06	6.75e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.55e-06	6.62e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL6—systemic lupus erythematosus	1.46e-06	6.22e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL6—systemic lupus erythematosus	1.44e-06	6.12e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL6—systemic lupus erythematosus	1.41e-06	6e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.4e-06	5.96e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.34e-06	5.7e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	1.32e-06	5.61e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL6—systemic lupus erythematosus	1.31e-06	5.57e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.22e-06	5.21e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.02e-06	4.33e-05	CbGpPWpGaD
